PEOPLE - Changes at Arrow International:
This article was originally published in Clinica
Executive Summary
Reading, Pennsylvania-based Arrow International, a manufacturer of catheters for cardiac care, has made several management changes. Frederick Hirt has been promoted to senior vice-president of finance and CFO. He will also continue his role as a member of the management executive committee. Fellow member Carl Staples, head of human resources, has been appointed senior vice-president of HR. Philip Croxford has been promoted to group vice-president of critical care and cardiac assist and will become a member of the committee. James Hatlan has been promoted to senior vice-president of manufacturing and also becomes a member of the committee. The firm also announced the retirement of Philip Fleck, Arrow's president and COO, effective December 31 2004.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.